Hypothalamic Neoplasms: Clinical Trials

2 trials for Hypothalamic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2

Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraoperative Imaging of Pituitary Adenomas by OTL
OTL38 - Neoplasms, Pituitary Neoplasms
Phase 1TerminatedUniversity of Pennsylvania332015-10-012019-08-06
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1TerminatedNational Cancer Institute (NCI)1292010-03-012014-11-05

Narrower conditions

Pituitary Neoplasms (2)  ·  Adenoma, Acidophil (1)  ·  Adenoma, Basophil (1)  ·  Adenoma, Chromophobe (1)  ·  Astrocytoma (1)  ·  Burkitt Lymphoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Familial ependymoma (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Medulloblastoma (1)  ·  Neoplasms (1)  ·  Oligodendroglioma (1)  ·  Optic Nerve Glioma (1)

Broader conditions

Brain Diseases (2)  ·  Brain Neoplasms (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Hypothalamic Diseases (2)  ·  Neoplasms by Site (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Pituitary Diseases (2)  ·  Supratentorial Neoplasms (2)  ·  Adenoma (1)  ·  Cerebral Ventricle Neoplasms (1)

Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Pafolacianine (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  University of Pennsylvania (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Najat Daw (1)

NIH funding

U01CA097452 (1)